B G Angeja

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2
    B G Angeja
    Genentech Inc, South San Francisco, California, USA
    Am J Cardiol 87:627-30, A9. 2001
  2. ncbi request reprint Predictors of door-to-balloon delay in primary angioplasty
    Brad G Angeja
    Cardiovascular Division, Department of Medicine, The University of California, San Francisco, San Francisco, California 94143, USA
    Am J Cardiol 89:1156-61. 2002
  3. ncbi request reprint Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy
    Brad G Angeja
    Cardiovascular Division, Department of Medicine, University of California, San Francisco, Calif 94143, USA
    Am Heart J 144:649-56. 2002
  4. ncbi request reprint Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial
    B G Angeja
    Cardiovascular Division, University of California San Francisco, San Francisco, California 94143 0124, USA
    Am J Cardiol 88:1240-5. 2001
  5. ncbi request reprint Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
    B G Angeja
    Department of Medicine, University of California, San Francisco, California 94143, USA
    J Am Coll Cardiol 38:1297-301. 2001
  6. ncbi request reprint Use of reperfusion therapies in elderly patients with acute myocardial infarction
    B G Angeja
    Department of Medicine, University of California, San Francisco, Moffitt Hospital, 94143 0124, USA
    Drugs Aging 18:587-96. 2001
  7. ncbi request reprint Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women
    M G Shlipak
    General Internal Medicine Section, Veterans Affairs Medical Center, Department of Medicine, University of California, San Francisco, USA
    Circulation 104:2300-4. 2001
  8. ncbi request reprint The smoker's paradox: insights from the angiographic substudies of the TIMI trials
    Brad G Angeja
    Cardiovascular Division, Department of Medicine, University of California, San Francisco, USA
    J Thromb Thrombolysis 13:133-9. 2002
  9. ncbi request reprint TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging
    Brad G Angeja
    Department of Medicine, The University of California, San Francisco, USA
    Circulation 105:282-5. 2002
  10. ncbi request reprint Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery
    C Michael Gibson
    Harvard Clinical Research Institute and Brigham and Women s Hospital, Boston, MA 02215, USA
    J Thromb Thrombolysis 13:9-12. 2002

Detail Information

Publications10

  1. ncbi request reprint Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2
    B G Angeja
    Genentech Inc, South San Francisco, California, USA
    Am J Cardiol 87:627-30, A9. 2001
    ..However, the relative benefit was less evident in older patients and women, and some older subgroups did not benefit from treatment...
  2. ncbi request reprint Predictors of door-to-balloon delay in primary angioplasty
    Brad G Angeja
    Cardiovascular Division, Department of Medicine, The University of California, San Francisco, San Francisco, California 94143, USA
    Am J Cardiol 89:1156-61. 2002
    ..These findings may help design treatment algorithms to minimize delay, thus improving the survival benefit of pPTCA. These results may also help design trials of combination reperfusion strategies...
  3. ncbi request reprint Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy
    Brad G Angeja
    Cardiovascular Division, Department of Medicine, University of California, San Francisco, Calif 94143, USA
    Am Heart J 144:649-56. 2002
    ..We studied the angiographic and electrocardiographic responses to thrombolytic agents in patients with diabetes; in particular ST-segment resolution as a measure of microvascular flow...
  4. ncbi request reprint Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial
    B G Angeja
    Cardiovascular Division, University of California San Francisco, San Francisco, California 94143 0124, USA
    Am J Cardiol 88:1240-5. 2001
    ..33). Adjustment for small baseline differences in this randomized sample did not change the results. Thus, across the range of estimated weight categories corresponding to each TNK dose, TNK is as safe and effective as t-PA...
  5. ncbi request reprint Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
    B G Angeja
    Department of Medicine, University of California, San Francisco, California 94143, USA
    J Am Coll Cardiol 38:1297-301. 2001
    ..We examined the association of hormone therapy (HRT) with hemorrhagic and ischemic stroke among postmenopausal women with acute myocardial infarction (AMI)...
  6. ncbi request reprint Use of reperfusion therapies in elderly patients with acute myocardial infarction
    B G Angeja
    Department of Medicine, University of California, San Francisco, Moffitt Hospital, 94143 0124, USA
    Drugs Aging 18:587-96. 2001
    ..Finally, newer, more fibrin-specific thrombolytics may decrease the bleeding risk associated with thrombolytic therapy...
  7. ncbi request reprint Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women
    M G Shlipak
    General Internal Medicine Section, Veterans Affairs Medical Center, Department of Medicine, University of California, San Francisco, USA
    Circulation 104:2300-4. 2001
    ..CONCLUSIONS: Postmenopausal HRT appears to be associated with reduced mortality after myocardial infarction. This finding could be caused by therapeutic effect of HRT, selection and adherence bias, or some combination of both...
  8. ncbi request reprint The smoker's paradox: insights from the angiographic substudies of the TIMI trials
    Brad G Angeja
    Cardiovascular Division, Department of Medicine, University of California, San Francisco, USA
    J Thromb Thrombolysis 13:133-9. 2002
    ..We determined the clinical risk profiles and coronary flow characteristics of patients in the TIMI trials according to smoking status, focusing on microvascular flow...
  9. ncbi request reprint TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging
    Brad G Angeja
    Department of Medicine, The University of California, San Francisco, USA
    Circulation 105:282-5. 2002
    ..0001). The difference in infarct size by TMPG persisted when stratified by category of ST resolution...
  10. ncbi request reprint Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery
    C Michael Gibson
    Harvard Clinical Research Institute and Brigham and Women s Hospital, Boston, MA 02215, USA
    J Thromb Thrombolysis 13:9-12. 2002
    ..To determine whether APSTD is associated with abnormal blood flow in the uninvolved or non-culprit LAD, we assessed TIMI flow grades and corrected TIMI frame counts (CTFC) in both the culprit and non-culprit arteries of IMI patients...